GSK to Build New Global Research Center in Cambridge

MT Newswires Live
Jul 28

GSK (GSK) said Tuesday it plans to establish a new global research and development facility within Cambridge Biomedical Campus in the UK and spend 400 million British pounds (about $532 million) over three years to construct the center and upgrade existing laboratories in Ware.

The company said it will move its R&D operations in the UK to the new facility, which is expected to house over 1,000 researchers, and exit its current site in Stevenage through a gradual employee relocation ending by 2029.

Shares of the company were up 2.1% in Tuesday premarket activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10